Therefore, in this research, we plan to overexpress or knock down LOX-1 to explore its effects in alcoholic cardiomyopathy both in vitro and in vivo to provide new insights and the potential therapeutic target for the treatment of alcoholic cardiomyopathy. Here, OLR1 is linked to alcoholic cardiomyopathy.